(Q54135688)

25 May 2018

title

Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients. (English)

1 reference

25 May 2018

0 references

Hunter KD

1

1 reference

25 May 2018

Gibson J

2

1 reference

25 May 2018

Lockhart P

3

1 reference

25 May 2018

Pithie A

4

1 reference

25 May 2018

Bagg J

5

1 reference

25 May 2018

publication date

1 May 1998

1 reference

25 May 2018

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

published in

1 reference

25 May 2018

volume

85

1 reference

25 May 2018

issue

5

1 reference

25 May 2018

page(s)

558-564

1 reference

25 May 2018

The human immunodeficiency virus: infectivity and mechanisms of pathogenesis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

Treatment of oral candidiasis in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

Fluconazole in the treatment of oropharyngeal candidosis in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

Fluconazole response patterns in HIV-infected patients with oropharyngeal candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

Can we prevent azole resistance in fungi?

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

Antifungal susceptibility testing: technical advances and potential clinical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

High prevalence of antifungal resistance in Candida spp. from patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

A longitudinal study of the change in resistance patterns and genetic relationship of oralCandida albicansfrom HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2898%2990291-8

7 January 2021

10.1016/S1079-2104(98)90291-8

Identifiers

DOI

1 reference

25 May 2018

PubMed ID

9619674

1 reference

25 May 2018